Taro Pharmaceutical
TARO
$42.20
Share price
-0.07%
Change (1 day)
65.10%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) - Total debt
Total debt on the balance sheet as of March 2023 : $1.95 M
According to Taro Pharmaceutical's latest financial reports the company's total debt is $1.95 M. A company’s total debt is the sum of all current and non-current debts.
Taro Pharmaceutical - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-03-31 | $1.95 M | -11.52% |
| 2022-03-31 | $2.2 M | 30.49% |
| 2021-03-31 | $1.68 M | 11.56% |
| 2020-03-31 | $1.51 M | |
| 2019-03-31 | $N/A | |
| 2015-03-31 | $5.88 M | -67.04% |
| 2014-03-31 | $17.86 M | -37.54% |
| 2013-03-31 | $28.59 M | |
| 2011-12-31 | $44.68 M | -24.79% |
| 2010-12-31 | $59.42 M | -63.71% |
| 2009-12-31 | $0.16 B | -12.91% |
| 2008-12-31 | $0.18 B | -13.23% |
| 2007-12-31 | $0.21 B | -9% |
| 2006-12-31 | $0.23 B | -9.08% |
| 2005-12-31 | $0.26 B | -2.72% |
| 2004-12-31 | $0.26 B | 34.3% |
| 2003-12-31 | $0.20 B | 249.28% |
| 2002-12-31 | $57.39 M | 11.44% |
| 2001-12-31 | $51.5 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 1,504,105.13% | 🇺🇸 USA |
 Novartis NVS | $26.34 B | 1,351,079.49% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 3,632,976.92% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 1,797,592.31% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | 1,176,151.28% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 1,033,387.18% | 🇮🇱 Israel |